Health Care & Life Sciences » Pharmaceuticals | Clearside Biomedical Inc.

Clearside Biomedical Inc.

Clearside Biomedical Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.52
Market Cap
$40.42 M
Shares Outstanding
37.6 M
Public Float
24.49 M

Profile

Address
900 North Point parkway
Alpharetta Georgia 30005
United States
Employees -
Website http://www.clearsidebio.com
Updated 07/08/2019
Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H.

Financials

View All
Created with Highcharts 5.0.14Clearside Biomedical Inc.Net Income. Fiscal year is January-December. All values USD Thousands.7 2547 25410 18910 18917 63917 63925 88225 88258 97558 97582 81882 818201320142015201620172018020k40k60k80k100k
Created with Highcharts 5.0.14Clearside Biomedical Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.00000052052034534530302013201420152016201720180100200300400500600

Daniel H. White
President, Chief Executive Officer & Director
William D. Humphries
Chairman